CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-11 | SCS Sponsor III LLC Former Director and 10% Owner | Other disposition | −6,860,000 | 0 | ||
| 2022-07-11 | SCS Sponsor III LLC Former Director and 10% Owner | Option exercise · Class B ordinary shares | −6,220,000 | 0 | ||
| 2022-07-11 | Weber Darin J. SVP of Regulatory Development | Grant or award · Class B Ordinary Shares | +676,356 | 676,356 | ||
| 2022-07-11 | Weber Darin J. SVP of Regulatory Development | Grant or award · Common Units in ProKidney LP | +676,356 | 676,356 | ||
| 2022-07-11 | Bertram Timothy Chief Executive Officer | Grant or award · Class B Ordinary Shares | +4,944,938 | 4,944,938 | ||
| 2022-07-11 | Bertram Timothy Chief Executive Officer | Grant or award · Common Units in ProKidney LP | +4,944,938 | 4,944,938 | ||
| 2022-07-11 | Pereira Brian JG Director | Grant or award · Class B Ordinary Shares | +1,514,326 | 1,514,326 | ||
| 2022-07-11 | Pereira Brian JG Director | Grant or award · Common Units in ProKidney LP | +1,514,326 | 1,514,326 | ||
| 2022-07-11 | Jain Deepak Chief Operating Officer | Grant or award · Class B Ordinary Shares | +1,567,939 | 1,567,939 | ||
| 2022-07-11 | Jain Deepak Chief Operating Officer | Grant or award · Common Units in ProKidney LP | +1,567,939 | 1,567,939 | ||
| 2022-07-11 | McKenzie Libbie Parker Chief Medical Officer | Grant or award · Class B Ordinary Shares | +327,713 | 327,713 | ||
| 2022-07-11 | McKenzie Libbie Parker Chief Medical Officer | Grant or award · Common Units in ProKidney LP | +327,713 | 327,713 | ||
| 2022-07-11 | Coulston James Chief Financial Officer | Grant or award · Class B Ordinary Shares | +716,850 | 716,850 | ||
| 2022-07-11 | Coulston James Chief Financial Officer | Grant or award · Common Units in ProKidney LP | +716,850 | 716,850 | ||
| 2022-07-11 | Legorreta Pablo G. Director | Grant or award · Class B Ordinary Shares | +94,677,968 | 94,677,968 | ||
| 2022-07-11 | Legorreta Pablo G. Director | Grant or award · Common Units in ProKidney LP | +94,677,968 | 94,677,968 | ||
| 2022-07-11 | Legorreta Pablo G. Director | Grant or award · Earnout Rights | +10,500,000 | 10,500,000 | ||
| 2022-07-11 | MARAGANORE JOHN Director | Grant or award · Class B Ordinary Shares | +614,013 | 614,013 | ||
| 2022-07-11 | MARAGANORE JOHN Director | Grant or award · Common Units in ProKidney LP | +614,013 | 614,013 | ||
| 2022-07-11 | Girolamo Todd C Chief Legal Officer | Grant or award · Class B Ordinary Shares | +327,713 | 327,713 |
Page 11 of 12 · 231 trades